Modulation of p53 expression in cancer-associated fibroblasts prevents peritoneal metastasis of gastric cancer

Modulation of p53 expression in cancer-associated fibroblasts prevents peritoneal metastasis of gastric cancer

Cancer-associated fibroblasts (CAFs) in the tumor microenvironment are associated with the establishment and progression of peritoneal metastasis. This study investigated the efficacy of replicative oncolytic adenovirus-mediated p53 gene therapy (OBP-702) against CAFs and peritoneal metastasis of ga...

Full description

Bibliographic Details
Main Authors:	Toshihiro Ogawa, Satoru Kikuchi, Motoyasu Tabuchi, Ema Mitsui, Yuta Une, Hiroshi Tazawa, Shinji Kuroda, Kazuhiro Noma, Toshiaki Ohara, Shunsuke Kagawa, Yasuo Urata, Toshiyoshi Fujiwara
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	Molecular Therapy: Oncolytics
Subjects:	peritoneal metastasis adenovirus gastric cancer cancer-associated fibroblast p53 oncolytic virus
Online Access:	http://www.sciencedirect.com/science/article/pii/S2372770522000614

Similar Items

Boosting Replication and Penetration of Oncolytic Adenovirus by Paclitaxel Eradicate Peritoneal Metastasis of Gastric Cancer
by: Wataru Ishikawa, et al.
Published: (2020-09-01)

Functional remodeling of intraperitoneal macrophages by oncolytic adenovirus restores anti-tumor immunity for peritoneal metastasis of gastric cancer
by: Motoyasu Tabuchi, et al.
Published: (2024-06-01)

Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer
by: Hiroyuki Araki, et al.
Published: (2022-12-01)

Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity
by: Tomoko Ohtani, et al.
Published: (2024-11-01)

Novel treatment strategy targeting interleukin-6 induced by cancer associated fibroblasts for peritoneal metastasis of gastric cancer
by: Ema Mitsui, et al.
Published: (2025-01-01)

Oncolytic Adenoviruses in Cancer Treatment
by: Ramon Alemany
Published: (2014-02-01)

Oncolytic viruses for cancer immunotherapy
by: Otto Hemminki, et al.
Published: (2020-06-01)

Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer
by: Takeshi Koujima, et al.
Published: (2020-06-01)

p53-armed oncolytic virotherapy induces abscopal effect in osteosarcoma by promoting immunogenic cell death
by: Koji Demiya, et al.
Published: (2024-09-01)

Oncolytic adenovirus armed with IL-24 Inhibits the growth of breast cancer <it>in vitro</it> and <it>in vivo</it>
by: Zhu Wei, et al.
Published: (2012-05-01)

DNA-damaging cancer cells to improve virotherapy
by: Marc Garcia-Moure, et al.
Published: (2022-12-01)

A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression
by: Wenjuan Cao, et al.
Published: (2017-08-01)

Portrait of a Leader in Immunotherapeutics<subtitle>Oncolytic viruses for treatment of cancer</subtitle>
by: Akseli Hemminki
Published: (2012-08-01)

Prostate Cancer-Specific of DD3-driven oncolytic virus-harboring mK5 gene
by: Hao Jiali, et al.
Published: (2018-12-01)

Long-Term Follow-Up of Phase I Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy for Treatment of Metastatic Pancreatic Cancer
by: Aseem Rai Bhatnagar, et al.
Published: (2024-05-01)

Multidisciplinary oncolytic virotherapy for gastrointestinal cancer
by: Toshiyoshi Fujiwara
Published: (2019-07-01)

Tropism and transduction of oncolytic adenovirus vectors in prostate cancer therapy
by: Chuang Wu, et al.
Published: (2021-10-01)

Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation
by: Martí Farrera-Sal, et al.
Published: (2021-09-01)

An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy
by: Muhammad Naveed, et al.
Published: (2024-11-01)

Oncolytic and immunotherapeutic CG0070 adenovirus for high-risk bacillus calmette-guerin unresponsive bladder cancer
by: Evan Austin, et al.
Published: (2021-12-01)

Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy
by: Ee Wern Tan, et al.
Published: (2022-10-01)

Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion
by: Matthew Glen Robertson, et al.
Published: (2021-03-01)

Oncolytic Adenovirus, a New Treatment Strategy for Prostate Cancer
by: Kaiyi Yang, et al.
Published: (2022-12-01)

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma
by: Cristian Capasso, et al.
Published: (2016-04-01)

Oncolytic Adenoviruses in Gastrointestinal Cancers
by: Raquel T. Yokoda, et al.
Published: (2018-03-01)

Classification and Gene Features of Unverified HAdV in China, 2012-2019
by: MA Xiao, et al.
Published: (2021-06-01)

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
by: Yaohe Wang, et al.
Published: (2010-01-01)

Combination of <i>dl922-947</i> Oncolytic Adenovirus and G-Quadruplex Binders Uncovers Improved Antitumor Activity in Breast Cancer
by: Fabiana Napolitano, et al.
Published: (2022-08-01)

Interaction Analysis of Adenovirus L5 Protein With Pancreatic Cancer Cell Surface Receptor to Analyze Its Affinity for Oncolytic Virus Therapy
by: Maryum Nisar, et al.
Published: (2022-03-01)

Elimination of MYCN-Amplified Neuroblastoma Cells by Telomerase-Targeted Oncolytic Virus via MYCN Suppression
by: Terutaka Tanimoto, et al.
Published: (2020-09-01)

Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer
by: Lin Ang, et al.
Published: (2022-07-01)

Involvement in the tumor-infiltrating CD8+ T cell expression by the initial disease of remnant gastric cancer
by: Yoshihiko Kakiuchi, et al.
Published: (2022-11-01)

Advancing Lung Cancer Treatment with Combined c-Met Promoter-Driven Oncolytic Adenovirus and Rapamycin
by: Shih-Yao Chen, et al.
Published: (2024-09-01)

Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers
by: Camilla Heiniö, et al.
Published: (2022-08-01)

Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system
by: Nie Zhen-Lin, et al.
Published: (2012-11-01)

Ad-Apoptin-hTERTp-E1a Regulates Autophagy Through the AMPK-mTOR-eIF4F Signaling Axis to Reduce Drug Resistance of MCF-7/ADR Cells
by: Yaru Li, et al.
Published: (2021-11-01)

Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells
by: Janet Lei, et al.
Published: (2018-06-01)

Corrigendum: Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
by: Mingming Hu, et al.
Published: (2023-12-01)

Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
by: Mingming Hu, et al.
Published: (2023-11-01)

An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer
by: Maryum Nisar, et al.
Published: (2022-05-01)